ÂÜÀòÂÒÂ×

The Research and Development team at Kate Therapeutics focuses on innovating and advancing AAV-based gene therapies for muscle and heart diseases. Comprising a diverse group of scientists and researchers, the team conducts experiments to optimize gene delivery mechanisms, enhance safety profiles, and improve therapeutic efficacy. Their work involves developing new technology platforms, characterizing AAV capsids, and designing preclinical studies to facilitate the transition of promising therapies from the lab to clinical application.